Medical sales reps have long had a close relationship with physicians, providing services as a surgical consultant as well as a medtech dealer, but that dynamic may be about to change in a big way.
Hip surgeries are likely to become increasingly popular as the U.S. population ages, representing a significant cost burden for the healthcare system, but orthopedic surgeons say the procedure ultimately saves tens of thousands of dollars per patient.
Life science venture capital funding saw a major boost in the 2nd quarter as public markets smiled on biotech companies, but medical device makers saw a significant boost of their own – as long as they weren’t early-stage firms.
The healthcare space is getting a major influx of digital innovation, but much of it’s coming from outside the traditional parameters of the industry.
Last year may not have been a blockbuster one for medical device makers, but the industry posted steady gains in jobs, according to a new report from EP Vantage.
The analysis of nearly 100 small and large medtech companies found that jobs increased, on average, across the board. A closer look at the top 15 device makers found that jobs increased 6% overall and only 3 of the titans reduced their total headcount during the year, 2 of them by spinning out their pharma divisions.
MASSDEVICE ON CALL — More medical device giants offered their 2¢ on high-dollar mega-mergers, joining other companies in saying that they aren’t planning any billion-dollar buys just yet.
The funding environment for medical device startups isn’t a pretty scene, but there is a ray of sunshine through the gloom: lack of FDA approval is no longer a deal-breaker for a big exit.
In 2013 a few medtech companies managed "big exit M&A" deals (those worth $50 million or more) without having reached the FDA’s brass ring, according to a new report from Silicon Valley Bank.